Renoprotective Effects of DPP-4 Inhibitors
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely used in the treatment of patients with type 2 diabetes (T2D). DPP-4 inhibitors reduce glucose levels by inhibiting degradation of incretins. DPP-4 is a u...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2021-02-01
|
| Schriftenreihe: | Antioxidants |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2076-3921/10/2/246 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|